tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
INmune Bio announces video detailing findings from Phase 2 MINDFuL trial
PremiumThe FlyINmune Bio announces video detailing findings from Phase 2 MINDFuL trial
9d ago
Inmune Bio Reveals Promising XPro™ Trial Results
Premium
Company Announcements
Inmune Bio Reveals Promising XPro™ Trial Results
13d ago
INmune Bio announces analyses from Phase 2 MINDFuL trial, endpoint not met
Premium
The Fly
INmune Bio announces analyses from Phase 2 MINDFuL trial, endpoint not met
14d ago
INmune Bio downgraded to Underperform from Outperform at Scotiabank
PremiumThe FlyINmune Bio downgraded to Underperform from Outperform at Scotiabank
1M ago
INmune Bio downgraded to Neutral from Buy at BTIG
Premium
The Fly
INmune Bio downgraded to Neutral from Buy at BTIG
1M ago
Inmune Bio’s Xpro Alzheimer’s Trial Faces Challenges, Justifying Hold Rating
Premium
Ratings
Inmune Bio’s Xpro Alzheimer’s Trial Faces Challenges, Justifying Hold Rating
1M ago
INmune Bio downgraded at Raymond James after Alzheimer’s data ‘missed the mark’
PremiumThe FlyINmune Bio downgraded at Raymond James after Alzheimer’s data ‘missed the mark’
1M ago
Morning News Wrap-Up: Monday’s Biggest Stock Market Stories!
Premium
Market News
Morning News Wrap-Up: Monday’s Biggest Stock Market Stories!
1M ago
INmune Bio reports findings from Phase 2 MINDFuL trial of XPro
Premium
The Fly
INmune Bio reports findings from Phase 2 MINDFuL trial of XPro
1M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100